Skip to main content
Fig. 2 | Infectious Agents and Cancer

Fig. 2

From: Influence of insulin resistance on the development of hepatocellular carcinoma after antiviral treatment for non-cirrhotic patients with chronic hepatitis C

Fig. 2

Cumulative incidence of HCC according to insulin resistance (cut-off HOMA-IR 3.0) for non-SVR patients with a normal post-treatment ALT level (<40 U/L) and b high post-treatment ALT level (≥40 U/L). HCC, hepatocellular carcinoma; HOMA, homeostasis model assessment of insulin resistance; SVR, sustained virological response; ALT alanine aminotransferase

Back to article page

Infectious Agents and Cancer

ISSN: 1750-9378

Contact us